Dopamine disposition in the presynaptic process regulates the severity of methamphetamine-induced neurotoxicity

Annals of the New York Academy of Sciences

Volumn 1139, Issue , 2008, Pages 118-126

  Kuhn, Donald M ^a,b   Francescutti Verbeem, Dina M ^a,b   Thomas, David M ^b,c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

Clorgyline; Cytoplasm; Dopamine nerve ending; L DOPA; Methamphetamine; Microglia; Neurotoxicity; Reserpine; Synaptic vesicles

Indexed keywords

CARBIDOPA; CLORGYLINE; DOPAMINE; LEVODOPA; METHAMPHETAMINE; RESERPINE;

ANIMAL EXPERIMENT; CONFERENCE PAPER; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOPAMINE METABOLISM; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; FEMALE; INJURY SEVERITY; MICROGLIA; MOLECULAR INTERACTION; MOUSE; NEUROTOXICITY; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PRESYNAPTIC NERVE; SYNAPSE; SYNAPSE VESICLE;

EID: 53549094970     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1432.026     Document Type: Conference Paper

References (52)

1. Thompson, P.M., K.M. Hayashi, S.L. Simon, et al. 2004. Structural abnormalities in the brains of human subjects who use methamphetamine. J. Neurosci. 24 : 6028 6036.
2. Fleckenstein, A.E., T.J. Volz, E.L. Riddle, et al. 2007. New insights into the mechanism of action of amphetamines. Annu. Rev. Pharmacol. Toxicol. 47 : 681 698.
3. Yamamoto, B.K. & M.G. Bankson. 2005. Amphetamine neurotoxicity: cause and consequence of oxidative stress. Crit. Rev. Neurobiol. 17 : 87 117.
4. Davidson, C., A.J. Gow, T.H. Lee & E.H. Ellinwood. 2001. Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res. Brain Res. Rev. 36 : 1 22.
5. Jayanthi, S., M.T. McCoy, B. Ladenheim & J.L. Cadet. 2002. Methamphetamine causes coordinate tegulation of Src, Cas, Crk, and the Jun N-terminal kinase-Jun pathway. Mol. Pharmacol. 61 : 1124 1131.
6. Volkow, N.D., L. Chang, G.J. Wang, et al. 2001. Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J. Neurosci. 21 : 9414 9418.
7. Volkow, N.D., L. Chang, G.J. Wang, et al. 2001. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am. J. Psychiatry 158 : 377 382.
8. Thomas, D.M. & D.M. Kuhn. 2005. Attenuated microglial activation mediates tolerance to the neurotoxic effects of methamphetamine. J. Neurochem. 92 : 790 797.
9. Thomas, D.M., P.D. Walker, J.A. Benjamins, et al. 2004. Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation. J. Pharmacol. Exp. Ther. 311 : 1 7.
10. LaVoie, M.J., J.P. Card & T.G. Hastings. 2004. Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity. Exp. Neurol. 187 : 47 57.
11. Bowyer, J.F., D.L. Davies, L. Schmued, et al. 1994. Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J. Pharmacol. Exp. Ther. 268 : 1571 1580.
12. Streit, W.J. 2002. Microglia as neuroprotective, immunocompetent cells of the CNS. Glia. 40 : 133 139.
13. Hanisch, U.K. & H. Kettenmann. 2007. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10 : 1387 1394.
14. Block, M.L., L. Zecca & J.S. Hong. 2007. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 8 : 57 69.
15. Cadet, J.L., I.N. Krasnova, S. Jayanthi & J. Lyles. 2007. Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms. Neurotox Res. 11 : 183 202.
16. Cadet, J.L., S. Ali & C. Epstein. 1994. Involvement of oxygen-based radicals in methamphetamine-induced neurotoxicity: evidence from the use of CuZnSOD transgenic mice. Ann. N. Y. Acad. Sci. 738 : 388 391.
17. Imam, S.Z., G.D. Newport, Y. Itzhak, et al. 2001. Peroxynitrite plays a role in methamphetamine-induced dopaminergic neurotoxicity: evidence from mice lacking neuronal nitric oxide synthase gene or overexpressing copper-zinc superoxide dismutase. J. Neurochem. 76 : 745 749.
18. Klegeris, A., E.G. McGeer & P.L. McGeer. 2007. Therapeutic approaches to inflammation in neurodegenerative disease. Curr. Opin. Neurol. 20 : 351 357.
19. Streit, W.J. 2004. Microglia and Alzheimer's disease pathogenesis. J. Neurosci. Res. 77 : 1 8.
20. Benkovic, S.A., J.P. O'Callaghan & D.B. Miller. 2004. Sensitive indicators of injury reveal hippocampal damage in C57BL/6J mice treated with kainic acid in the absence of tonic-clonic seizures. Brain Res. 1024 : 59 76.
21. Kim, Y.S., D.H. Choi, M.L. Block, et al. 2007. A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation. FASEB J. 21 : 179 187.
22. Wagner, G.C., J.B. Lucot, C.R. Schuster & L.S. Seiden. 1983. Alpha-methyltyrosine attenuates and reserpine increases methamphetamine- induced neuronal changes. Brain Res. 270 : 285 288.
23. Schmidt, C.J., J.K. Ritter, P.K. Sonsalla, et al. 1985. Role of dopamine in the neurotoxic effects of methamphetamine. J. Pharmacol. Exp. Ther. 233 : 539 544.
24. Albers, D.S. & P.K. Sonsalla. 1995. Metham-phetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents. J. Pharmacol. Exp. Ther. 275 : 1104 1114.
25. Fornstedt, B. & A. Carlsson. 1989. A marked rise in 5-S-cysteinyl-dopamine levels in guinea-pig striatum following reserpine treatment. J. Neural Transm. 76 : 155 161.
26. LaVoie, M.J. & T.G. Hastings. 1999. Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. J. Neurosci. 19 : 1484 1491.
27. Montine, T.J., M.J. Picklo, V. Amarnath, et al. 1997. Neurotoxicity of endogenous cysteinylcatechols. Exp. Neurol. 148 : 26 33.
28. Spencer, J.P., M. Whiteman, P. Jenner & B. Halliwell. 2002. 5-s-Cysteinyl-conjugates of catecholamines induce cell damage, extensive DNA base modification and increases in caspase-3 activity in neurons. J. Neurochem. 81 : 122 129.
29. Kuhn, D.M., D.M. Francescutti-Verbeem & D.M. Thomas. 2006. Dopamine quinones activate microglia and induce a neurotoxic gene expression profile: relationship to methamphetamine-induced nerve ending damage. Ann. N. Y. Acad. Sci. 1074 : 31 41.
30. Thomas, D.M., D.M. Francescutti-Verbeem & D.M. Kuhn. 2006. Gene expression profile of activated microglia under conditions associated with dopamine neuronal damage. FASEB J. 20 : 515 517.
31. Le, W., D. Rowe, W. Xie, et al. 2001. Microglial activation and dopaminergic cell injury: An in vitro model relevant to Parkinson's Disease. J. Neurosci. 21 : 8447 8455.
32. Thomas, D.M., D.M. Francescutti-Verbeem & D.M. Kuhn. 2008. The newly synthesized pool of dopamine determines the severity of methamphetamine-induced neurotoxicity. J. Neurochem. 105 : 605 616.
33. Thomas, D.M., D.M. Francescutti-Verbeem, X. Liu & D.M. Kuhn. 2004. Identification of differentially regulated transcripts in mouse striatum following methamphetamine treatment: an oligonucleotide microarray approach. J. Neurochem. 88 : 380 393.
34. Streit, W.J. 1990. An improved staining method for rat microglial cells using the lectin from Griffonia simplicifolia (GSA I-B4). J. Histochem. Cytochem. 38 : 1683 1686.
35. Thomas, D.M., J. Dowgiert, T.J. Geddes, et al. 2004. Microglial activation is a pharmacologically specific marker for the neurotoxic amphetamines. Neurosci. Lett. 367 : 349 354.
36. Butcher, S.P., I.S. Fairbrother, J.S. Kelly & G.W. Arbuthnott. 1988. Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study. J. Neurochem. 50 : 346 355.
37. Fon, E.A., E.N. Pothos, B.C. Sun, et al. 1997. Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action. Neuron. 19 : 1271 1283.
38. O'Dell, S.J., F.B. Weihmuller & J.F. Marshall. 1991. Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity. Brain Res. 564 : 256 260.
39. Weihmuller, F.B., S.J. O'Dell & J.F. Marshall. 1993. L-dopa pretreatment potentiates striatal dopamine overflow and produces dopamine terminal injury after a single methamphetamine injection. Brain Res. 623 : 303 307.
40. Fumagalli, F., R.R. Gainetdinov, Y.M. Wang, et al. 1999. Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice. J. Neurosci. 19 : 2424 2431.
41. Larsen, K.E., E.A. Fon, T.G. Hastings, et al. 2002. Methamphetamine- induced degeneration of dopaminergic neurons involves autophagy and upregulation of dopamine synthesis. J. Neurosci. 22 : 8951 8960.
42. Pu, C., J.E. Fisher, G.D. Cappon & C.V. Vorhees. 1994. The effects of amfonelic acid, a dopamine uptake inhibitor, on methamphetamine-induced dopaminergic terminal degeneration and astrocytic response in rat striatum. Brain Res. 649 : 217 224.
43. Schmidt, C.J. & J.W. Gibb. 1985. Role of the dopamine uptake carrier in the neurochemical response to methamphetamine: effects of amfonelic acid. Eur. J. Pharmacol. 109 : 73 80.
44. Marek, G.J., G. Vosmer & L.S. Seiden. 1990. Dopamine uptake inhibitors block long-term neurotoxic effects of methamphetamine upon dopaminergic neurons. Brain Res. 513 : 274 279.
45. Fumagalli, F., R.R. Gainetdinov, K.J. Valenzano & M.G. Caron. 1998. Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter. J. Neurosci. 18 : 4861 4869.
46. Nappi, A.J. & E. Vass. 2001. The effects of nitric oxide on the oxidations of l-dopa and dopamine mediated by tyrosinase and peroxidase. J. Biol. Chem. 276 : 11214 11222.
47. Kuhn, D.M., R.E. Arthur, Jr., D.M. Thomas & L.A. Elferink. 1999. Tyrosine hydroxylase is inactivated by catechol-quinones and converted to a redox-cycling quinoprotein: possible relevance to Parkinson's disease. J. Neurochem. 73 : 1309 1317.
48. Park, S.U., J.V. Ferrer, J.A. Javitch & D.M. Kuhn. 2002. Peroxynitrite inactivates the human dopamine transporter by modification of cysteine 342: potential mechanism of neurotoxicity in dopamine neurons. J. Neurosci. 22 : 4399 4405.
49. Whitehead, R.E., J.V. Ferrer, J.A. Javitch & J.B. Justice. 2001. Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter. J. Neurochem. 76 : 1242 1251.
50. Yuan, J., B.T. Callahan, U.D. McCann & G.A. Ricaurte. 2001. Evidence against an essential role of endogenous brain dopamine in methamphetamine- induced dopaminergic neurotoxicity. J. Neurochem. 77 : 1338 1347.
51. Miller, D.B. & J.P. O'Callaghan. 1994. Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse. J. Pharmacol. Exp. Ther. 270 : 752 760.
52. Lobsiger, C.S. & D.W. Cleveland. 2007. Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease. Nat. Neurosci. 10 : 1355 1360.